Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.
Urology|July 22, 1998
Comparison of goserelin and leuprolide in combined androgen blockade therapyM F Sarosdy, P F Schellhammer, R Sharifi, et al.
Urologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.
Urology|July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialM F Sarosdy, B A Lowe, P F Schellhammer, et al.
JAMA|August 28, 1996
Results of radical prostatectomy in men with clinically localized prostate cancerG S Gerber, R A Thisted, P T Scardino, et al.
Urologic Oncology|January 13, 2011
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group studyR W Devere White, A D Deitch, H Tesluk, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
The New England Journal of Medicine|September 8, 2010
Sipuleucel-T immunotherapy for castration-resistant prostate cancerPhilip W Kantoff, Celestia S Higano, Neal D Shore, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.
Urology|July 22, 1998
Comparison of goserelin and leuprolide in combined androgen blockade therapyM F Sarosdy, P F Schellhammer, R Sharifi, et al.
Urologic Oncology|January 13, 2011
Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group studyD L Lamm, B A Blumenstein, E David Crawford, et al.
Urology|July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialM F Sarosdy, B A Lowe, P F Schellhammer, et al.
JAMA|August 28, 1996
Results of radical prostatectomy in men with clinically localized prostate cancerG S Gerber, R A Thisted, P T Scardino, et al.
Urologic Oncology|January 13, 2011
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group studyR W Devere White, A D Deitch, H Tesluk, et al.
European Urology|April 15, 2000
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. A Southwest Oncology Group StudyR W deVere White, A D Deitch, S Daneshmand, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
The New England Journal of Medicine|September 8, 2010
Sipuleucel-T immunotherapy for castration-resistant prostate cancerPhilip W Kantoff, Celestia S Higano, Neal D Shore, et al.
Pageof 33